GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC
BSE2815.20-22.65 (-0.8 %)
PREV CLOSE ( ) 2837.85
OPEN PRICE ( ) 2850.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2815.20 (6)
VOLUME 983
TODAY'S LOW / HIGH ( )2800.00 2850.00
52 WK LOW / HIGH ( )2040 2990
NSE2820.60-26.45 (-0.93 %)
PREV CLOSE( ) 2847.05
OPEN PRICE ( ) 2820.35
BID PRICE (QTY) 2820.60 (995)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 8194
TODAY'S LOW / HIGH( ) 2805.00 2843.60
52 WK LOW / HIGH ( )2020 2994.9
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 13-11 1924
Management Info
D S Parekh - Chairman A Vaidheesh - Managing Director
Registered Office

Address Dr Annie Besant Road,Worli,,
Mumbai,
Maharashtra-400030

Phone 022-24959595

Email askus@gsk.com

Website www.gsk-india.com

Registrars Details
Karvy Computershare Pvt Ltd
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
28Jun Announcement under Regulation 30 (LOD
Pursuant to clause 47 of the Listing Obligations and Disclosure Requirem..
25May Board Meeting-Outcome of Board Meeting
we are pleased to furnish the following information: 1. Dividend The..
08May Announcement under Regulation 30 (LOD
Pursuant to clause 47 of the Listing Obligations and Disclosure Requirem..
30Apr Board to consider FY18 results & Divi
GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that a meeting of t..
16Mar Glaxosmithkline Pharmaceuticals inform
Pursuant to Regulation 30 and Schedule III (A) (7) of the Listing and Di..
Financials
Rs. in Millions
QTR Mar 18 ANNUAL 18
Net Profit1055.53519.8
Gross Profit 1636.1 5415.8
Operating Profit 1731.65619.6
Net Sales 7486.228958.8
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Merck (BSE)
 2303.50 (4.75%)
M.Cap (Rs. in Cr)3823.67
Sanofi India (BSE)
 5513.90 (0.50%)
M.Cap (Rs. in Cr)12698.85
Pfizer (BSE)
 2569.15 (0.56%)
M.Cap (Rs. in Cr)11753.28
Solara Active Pharma (BSE)
 166.60 (8.25%)
M.Cap (Rs. in Cr)411.07
Aarti Drugs (BSE)
 526.20 (1.17%)
M.Cap (Rs. in Cr)1240.89
Shareholding Pattern
PROMOTERS 75%
NON-INSTITUTION 12.43%
FI/BANKS/INSURANCE 8.32%
MUTUAL FUNDS/UTI 2.65%
FII 0%
GOVERNMENT 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal, Tel no: 022-40790032, Mobile no- 9773104340, E-mail id- Complaince@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.